Effects of low-dose thiazide diuretics on fasting plasma glucose and serum potassium-a meta-analysis

Journal of the American Society of Hypertension

Volumn 7, Issue 6, 2013, Pages 454-466

  Mukete, Bertrand N ^a   Rosendorff, Clive ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chlorthalidone; diuretics; glucose; hydrochlorothiazide; hypertension; hypokalemia; potassium; thiazide

Indexed keywords

AMLODIPINE; AMLODIPINE PLUS BENAZEPRIL; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE; BENDROFLUMETHIAZIDE; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOSARTAN; PLACEBO; PROPRANOLOL; THIAZIDE DIURETIC AGENT; VALSARTAN;

ARTICLE; CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; META ANALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW;

CHLORTHALIDONE; DIURETICS; GLUCOSE; HYDROCHLOROTHIAZIDE; HYPERTENSION; HYPOKALEMIA; POTASSIUM; THIAZIDE;

BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; HUMANS; HYPERTENSION; HYPOKALEMIA; POTASSIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 84890441215     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.05.004     Document Type: Article

References (47)

1. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report JAMA 289 2003 2560 2572
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (allhat) JAMA 288 2002 2981 2997
3. S.S. Yoon, Y. Ostchega, and T. Louis Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008 NCHS Data Brief 2010 1 8
4. N.M. Kaplan Problems with the use of diuretics in the treatment of hypertension Am J Nephrol 6 1986 1 5
5. C. Manrique, M. Johnson, and J.R. Sowers Thiazide diuretics alone or with beta-blockers impair glucose metabolism in hypertensive patients with abdominal obesity Hypertension 55 2010 15 17
6. A.J. Zillich, J. Garg, S. Basu, G.L. Bakris, and B.L. Carter Thiazide diuretics, potassium, and the development of diabetes: a quantitative review Hypertension 48 2006 219 224
7. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension Lancet 2 1981 539 543
8. G. Berglund, O. Andersson, O. Larsson, and L. Wilhelmsen Antihypertensive effect and side-effects of bendroflumethiazide and propranolol Acta Med Scand 199 1976 499 506
9. A. Dornhorst, S.H. Powell, and J. Pensky Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion Lancet 1 1985 123 126
10. P. Meneton, P. Ricordeau, A. Weill, P. Tuppin, S. Samson, and H. Allemand Evaluation of the agreement between guidelines and initial antihypertensive drug treatment using a national health care reimbursement database J Eval Clin Pract 18 2012 623 629
11. F.H. Messerli, H. Makani, A. Benjo, J. Romero, C. Alviar, and S. Bangalore Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials J Am Coll Cardiol 57 2011 590 600
12. F.H. Messerli, and S. Bangalore Antihypertensive efficacy of aliskiren: is hydrochlorothiazide an appropriate benchmark? Circulation 119 2009 371 373
13. M. Borenstein Introduction to meta-analysis 2009 John Wiley & Sons Chichester, UK
14. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
15. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
16. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
17. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
18. R.G. Orwin, and R.F. Boruch RRT meets RDD: statistical strategies for assuring response privacy in telephone surveys Public Opin Q 46 1983 560 571
19. G. Berglund, and O. Andersson Beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects Lancet 1 1981 744 747
20. D.H. Zappe, J.R. Sowers, W.A. Hsueh, S.M. Haffner, P.C. Deedwania, and V.A. Fonseca Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome J Clin Hypertens (Greenwich) 10 2008 894 903
21. P.J. Savage, S.L. Pressel, J.D. Curb, E.B. Schron, W.B. Applegate, and H.R. Black Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Shep cooperative research group Arch Intern Med 158 1998 741 751
22. A. Pareek, N. Karnik, S.B. Salagre, S.D. Zawar, V.K. Joglekar, and N. Chandurkar Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study Curr Med Res Opin 24 2008 1771 1779
23. N. Racine, P. Hamet, J.S. Sampalis, N. Longo, and N. Bastien A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome J Hum Hypertens 24 2010 739 748
24. S. Vardan, K.G. Mehrotra, S. Mookherjee, G.A. Willsey, J.D. Gens, and D.E. Green Efficacy and reduced metabolic side effects of a 15-mg chlorthalidone formulation in the treatment of mild hypertension. A multicenter study JAMA 258 1987 484 488
25. F.J. Martinez-Martin, H. Rodriguez-Rosas, I. Peiro-Martinez, P. Soriano-Perera, P. Pedrianes-Martin, and C. Comi-Diaz Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study J Hum Hypertens 25 2011 346 353
26. S.G. Chrysant Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-hydrochlorothiazide group Arch Intern Med 154 1994 737 743
27. M.A. Weber, G.L. Bakris, K. Jamerson, M. Weir, S.E. Kjeldsen, and R.B. Devereux Cardiovascular events during differing hypertension therapies in patients with diabetes J Am Coll Cardiol 56 2010 77 85
28. W.J. Elliott, and P.M. Meyer Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis Lancet 369 2007 201 207
29. J.M. Luther, and N.J. Brown The renin-angiotensin-aldosterone system and glucose homeostasis Trends Pharmacol Sci 32 2011 734 739
30. J.H. Helderman, D. Elahi, D.K. Andersen, G.S. Raizes, J.D. Tobin, and D. Shocken Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium Diabetes 32 1983 106 111
31. J.I. Barzilay, B.R. Davis, J.A. Cutler, S.L. Pressel, P.K. Whelton, and J. Basile Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med 166 2006 2191 2201
32. J.B. Kostis, A.C. Wilson, R.S. Freudenberger, N.M. Cosgrove, S.L. Pressel, and B.R. Davis Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes Am J Cardiol 95 2005 29 35
33. H. Tsuji, F.J. Venditti Jr., J.C. Evans, M.G. Larson, and D. Levy The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham heart study) Am J Cardiol 74 1994 232 235
34. P.M. Okin, S.E. Kjeldsen, L.H. Lindholm, B. Dahlof, and R.B. Devereux The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium Blood Press 21 2012 146 152
35. F.J. He, and G.A. MacGregor Beneficial effects of potassium on human health Physiol Plant 133 2008 725 735
36. P.K. Whelton, J. He, J.A. Cutler, F.L. Brancati, L.J. Appel, and D. Follmann Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials JAMA 277 1997 1624 1632
37. Multiple risk factor intervention trial Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group JAMA 248 1982 1465 1477
38. D.S. Siscovick, T.E. Raghunathan, B.M. Psaty, T.D. Koepsell, K.G. Wicklund, and X. Lin Diuretic therapy for hypertension and the risk of primary cardiac arrest N Engl J Med 330 1994 1852 1857
39. M.H. Alderman, S. Madhavan, W.L. Ooi, H. Cohen, J.E. Sealey, and J.H. Laragh Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension N Engl J Med 324 1991 1098 1104
40. L.V. Franse, M. Pahor, M. Di Bari, G.W. Somes, W.C. Cushman, and W.B. Applegate Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program Hypertension 35 2000 1025 1030
41. R.W. Schrier Diuretic treatment of systolic hypertension in the elderly Hypertension 35 2000 1031
42. M.A. Raebel Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers Cardiovasc Ther 30 2012 e156 e166
43. S.E. Warren, and D.T. O'Connor Hyperkalemia resulting from captopril administration JAMA 244 1980 2551 2552
44. N.J. Brown, and D.E. Vaughan Angiotensin-converting enzyme inhibitors Circulation 97 1998 1411 1420
45. S.A. Sadjadi, J.I. McMillan, N. Jaipaul, P. Blakely, and S.S. Hline A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers Ther Clin Risk Manag 5 2009 547 552
46. J. Blake, and R.B. Devereux Differential effects of direct antagonism of aii compared to ace inhibitors on serum potassium levels and azotemia in patients with severe congestive heart failure Congest Heart Fail 6 2000 193 196
47. H. Milon, and A. Baleydier [comparison of antihypertensive and metabolic effects of lisinopril 20 mg/hydrochlorothiazide 12.5 mg fixed combination and captopril 50 mg/hydrochlorothiazide 25 mg fixed combination] Therapie 52 1997 195 205